{"id":39681,"date":"2022-10-18T09:07:19","date_gmt":"2022-10-18T09:07:19","guid":{"rendered":"https:\/\/haberulus.net\/?p=39681"},"modified":"2022-10-18T09:07:19","modified_gmt":"2022-10-18T09:07:19","slug":"sgknin-odemedigi-kanser-ilaci-icin-onemli-karar","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=39681","title":{"rendered":"SGK\u2019n\u0131n \u00f6demedi\u011fi kanser ilac\u0131 i\u00e7in \u00f6nemli karar"},"content":{"rendered":"

\u0130zmir’de kanser hastas\u0131 Nurdan Y\u00fccemen, SGK’n\u0131n \u00f6demedi\u011fi 46 bin 624 TL’lik ila\u00e7 i\u00e7in dava a\u00e7t\u0131. ‘\u0130htiyati tedbir’ ba\u015fvurusu sonras\u0131 mahkeme, dava sonu\u00e7lan\u0131ncaya kadar ilac\u0131n paras\u0131n\u0131 SGK taraf\u0131ndan \u00f6denmesine h\u00fckmetti.\u00a0<\/b><\/p>\n

\u0130\u015f\u00e7i emeklisi Nurdan Y\u00fccemen\u2019e 1 y\u0131l \u00f6nce akci\u011fer kanseri tan\u0131s\u0131 konuldu.<\/p>\n

Y\u00fccemen\u2019in tedavisinde Sosyal G\u00fcvenlik Kurumu\u2019nca (SGK) kar\u015f\u0131lanan ila\u00e7lar\u0131n etkili olmad\u0131\u011f\u0131 saptand\u0131. Tetkiklerin ard\u0131ndan Y\u00fccemen\u2019e \u2018pembrolizumab\u2019 etken maddeli ak\u0131ll\u0131 ila\u00e7lardan yaz\u0131ld\u0131.<\/p>\n

Ancak SGK, ilac\u0131 Sa\u011fl\u0131k Uygulama Tebli\u011fi geri \u00f6deme listesinde olmad\u0131\u011f\u0131 gerek\u00e7esiyle kar\u015f\u0131lamad\u0131.<\/p>\n

Ayda 2 doz kullan\u0131lan ilac\u0131n 46 bin 624 TL\u2019li masraf\u0131n\u0131 \u00f6deyemeyen Y\u00fccemen, avukatlar\u0131 Halil \u0130brahim Karaa\u011fa\u00e7 ve Mehmet Onur \u00d6zk\u0131l\u0131n\u00e7 arac\u0131l\u0131\u011f\u0131 ile mahkemeye ba\u015fvurdu.<\/p>\n

Y\u00fccemen\u2019in kanser tedavisinde kullan\u0131lacak ba\u015fka bir ilac\u0131 olmad\u0131\u011f\u0131n\u0131 belirten 2 avukat, ya\u015fam hakk\u0131n\u0131n kutsall\u0131\u011f\u0131 gerek\u00e7esiyle konuyu mahkemeye ta\u015f\u0131d\u0131. 9\u2019uncu \u0130\u015f Mahkemesi\u2019nde a\u00e7\u0131lan dava g\u00f6r\u00fclmeye ba\u015flad\u0131.<\/p>\n

\u0130lac\u0131n dava sonu\u00e7lan\u0131ncaya kadar SGK taraf\u0131ndan kar\u015f\u0131lanmas\u0131 i\u00e7in \u2018ihtiyati tedbir\u2019 ba\u015fvurusu da yap\u0131ld\u0131.<\/p>\n

\"\"<\/p>\n

\u2018\u0130HT\u0130YAT\u0130 TEDB\u0130R\u2019 KARARI \u00c7IKTI<\/strong><\/p>\n

Talebi uygun bulan mahkeme, 12 Ekim\u2019de dava sonu\u00e7lan\u0131ncaya kadar ilac\u0131n paras\u0131n\u0131 SGK taraf\u0131ndan \u00f6denmesine h\u00fckmetti. Kararda, \u2018ihtiyati tedbir\u2019 talebinin teminats\u0131z olarak kabul\u00fcne karar verildi.<\/p>\n

\u2018Pembrolizumab\u2019 etken maddeli ilac\u0131n hekimin uygun g\u00f6rd\u00fc\u011f\u00fc tedavi s\u00fcresince, gerekti\u011finde sorumlusundan al\u0131nmak \u00fczere, kesinti yap\u0131lmaks\u0131z\u0131n hastanelerin onkoloji b\u00f6l\u00fcm\u00fcnden kar\u015f\u0131lanmas\u0131na h\u00fckmedildi.<\/p>\n

Kararda ayr\u0131ca Y\u00fccemen\u2019in hastal\u0131\u011f\u0131na ili\u015fkin T\u00fcrkiye\u2019deki standart tedavi ila\u00e7lar\u0131n\u0131n kullan\u0131lmas\u0131 halinde bu durumun sa\u011fl\u0131\u011f\u0131n\u0131 bozup, bozmayaca\u011f\u0131 ile ilgili de\u011ferlendirmeyi i\u00e7eren t\u0131bbi raporun al\u0131nd\u0131\u011f\u0131 tarihe kadar s\u00f6z konusu ilac\u0131n paras\u0131n\u0131n SGK taraf\u0131ndan kar\u015f\u0131lanmas\u0131 gerekti\u011fi belirtilerek, \u201cAra karar\u0131n taraflara tebli\u011fine, itiraz yolu a\u00e7\u0131k olmak \u00fczere dosya \u00fczerinde yap\u0131lan inceleme sonucunda karar verildi\u201d denildi.<\/p>\n

\u2018MAHKEME YER\u0130NDE B\u0130R KARAR VERD\u0130\u2019<\/strong><\/p>\n

M\u00fcvekkili Nurdan Y\u00fccemen\u2019in 3\u2019\u00fcnc\u00fc derece kanser hastas\u0131 oldu\u011funa dikkati \u00e7eken avukat Halil \u0130brahim Karaa\u011fa\u00e7,\u00a0 \u015f\u00f6yle konu\u015ftu:<\/p>\n

*Ayl\u0131k kullanmas\u0131 gereken 2 doz ila\u00e7 var. Bu ilac\u0131n maliyeti y\u00fckl\u00fc. Tedavide kar\u015f\u0131layabildi\u011fi miktar\u0131n\u0131 kar\u015f\u0131lad\u0131 ancak yeti\u015femedi\u011fi durumda bize ba\u015fvurdu. Konuyu yarg\u0131ya ta\u015f\u0131d\u0131k.<\/p>\n

*Mahkeme yerinde bir karar verdi. B\u00fct\u00fcn kanser hastalar\u0131n\u0131n, SGK taraf\u0131ndan kar\u015f\u0131lanmayan ila\u00e7lar\u0131 alma \u015fanslar\u0131 var.<\/p>\n

*Mahkemenin karar\u0131n\u0131 olumlu buluyoruz. Bir anayasa devleti oldu\u011fumuz da b\u00f6ylelikle tescillenmi\u015f oldu.<\/p>\n

Mahkeme karar\u0131n\u0131n emsal oldu\u011funu vurgulayan avukat Mehmet Onur \u00d6zk\u0131l\u0131n\u00e7 da \u201cBenzer durumu ya\u015fayan hastalara, umut olmas\u0131n\u0131 temennin ederim. M\u00fcvekkilimiz ad\u0131na davan\u0131n sonunda da olumlu bir sonu\u00e7 alaca\u011f\u0131m\u0131za eminim. Karardan \u00f6t\u00fcr\u00fc \u00e7ok mutluyuz\u201d diye konu\u015ftu.(DHA)<\/p>\n","protected":false},"excerpt":{"rendered":"

\u0130zmir’de kanser hastas\u0131 Nurdan Y\u00fccemen, SGK’n\u0131n \u00f6demedi\u011fi 46 bin 624 TL’lik ila\u00e7 i\u00e7in dava a\u00e7t\u0131. ‘\u0130htiyati tedbir’ ba\u015fvurusu sonras\u0131 mahkeme …<\/p>\n","protected":false},"author":1,"featured_media":39682,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[775,1564,1134,580,505],"class_list":["post-39681","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-dava","tag-ilac","tag-ilacin","tag-karar","tag-mahkeme"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/39681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39681"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/39681\/revisions"}],"predecessor-version":[{"id":39683,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/39681\/revisions\/39683"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/39682"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}